BioSpace News Archive

Homewood Health, Canada’s leader in mental health, trauma and addiction treatment, welcomes on board four highly-skilled and accomplished experts to Ravensview, its newest treatment centre located in North Saanich, British Columbia.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that NewYork-Presbyterian Hospital will expand its telehealth capabilities with Philips remote patient monitoring. T

The OrthoHealing Center, a recognized leader in Southern California orthopedic circles, is one of the first centers in the area to introduce a natural, state-of- the-art option for patients facing the daunting potential of major, invasive surgery.

BioKansas announced that Dennis Ridenour, President & CEO, will be stepping down, effective February 8th.

Organization earns singular rating for obligated group

LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that the Company has formed a scientific advisory board (SAB) to assist the Company in product positioning and its go-to-market strategy

According to the latest market report published by Research Report Insights titled ‘Global Triple-Negative Breast Cancer Treatment Market: Global Industry Analysis, Size, Sales and Forecast By 2026,’ the global triple-negative breast cancer treatment market is projected to reach US$ 727 Mn by the end of 2026and grow at a CAGR of 4.9% during the forecast period.

Having long been a trust-worthy supplier for chemicals widely applied in drug discovery, chemistry and life science, BOC Sciences’ management recently decides to take another step forward and broaden its business range.

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased AxoGen, Inc.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 7, 2019, at 4:30 p.m. EST to discuss its financial results for the fiscal 2019 first quarter ended December 31, 2018.